Abstract
In the multidrug resistant (MDR) pathogen Acinetobacter baumannii the global repressor H-NS was shown to modulate the expression of genes involved in pathogenesis and stress response. In addition, H-NS inactivation results in an increased resistance to colistin, and in a hypermotile phenotype an altered stress response. To further contribute to the knowledge of this key transcriptional regulator in A. baumannii behavior, we studied the role of H-NS in antimicrobial resistance. Using two well characterized A. baumannii model strains with distinctive resistance profile and pathogenicity traits (AB5075 and A118), complementary transcriptomic and phenotypic approaches were used to study the role of H-NS in antimicrobial resistance, biofilm and quorum sensing gene expression. An increased expression of genes associated with β-lactam resistance, aminoglycosides, quinolones, chloramphenicol, trimethoprim and sulfonamides resistance in the Δhns mutant background was observed. Genes codifying for efflux pumps were also up-regulated, with the exception of adeFGH. The wild-type transcriptional level was restored in the complemented strain. In addition, the expression of biofilm related genes and biofilm production was lowered when the transcriptional repressor was absent. The quorum network genes aidA, abaI, kar and fadD were up-regulated in Δhns mutant strains. Overall, our results showed the complexity and scope of the regulatory network control by H-NS (genes involved in antibiotic resistance and persistence). These observations brings us one step closer to understanding the regulatory role of hns to combat A. baumannii infections.
Subject terms: Microbiology, Antimicrobials, Biofilms, Pathogens
Introduction
Transcription, as a complex obligated process for gene expression, provides multiple targets for antimicrobial discovery. Among them, obvious candidates are transcriptional factors and regulators. While RNA polymerase and transcriptional factors are highly conserved across the bacterial kingdom, regulators can be more specific to each bacterium that must adapt to unique environments. Acinetobacter baumannii readily adjusts to the hostile environments it finds when it colonizes and infects different human body niches. A critical aspect of the adaptation strategies to survive and thrive in harsh conditions is the fine tuning of gene expression through the timely action of transcriptional regulators. Researchers have explored the regulation of antibiotic resistance and identified several two-component systems (TCSs) responsible for different mechanisms such as regulation of RND-type efflux pumps1–4.
A transcription factor of interest is H-NS, since it controls expression of many functions in bacteria, including adherence to biotic surfaces, quorum sensing, biofilm formation, and metabolism pathways5–9. In A. baumannii, H-NS regulates the expression of genes involved in a variety of biological processes like transport (e.g., autotransporters, type-VI secretion systems) and metabolism (e.g., phenylacetic acid degradation pathway)7. Interestingly, H-NS inactivation, reduces levels of resistance to colistin8, an antibiotic currently used as a last resource to treat multidrug resistant (MDR) A. baumannii infections. H-NS is also responsible for protecting against stress; it alleviates the deleterious effects produced by metallo-β-lactamase toxic precursors and protects against DNA-damaging agents such as mitomycin C and levofloxacin10. A recently described function of H-NS is the repression of the exopolysaccharide poly-N-acetylglucosamine synthesis and the expression of a protein belonging to the CsgG/HfaB family11. The expression of the A. baumannii H-NS is down regulated in environments containing human serum albumin (HSA) or HSA-containing fluids12,13. In sum, the regulatable nature of H-NS strongly suggests it plays a fundamental role in A. baumannii’s responses and adaptation to the conditions within the human body.
In this study, we demonstrate the role of H-NS in regulating expression of genes related to antibiotic resistance, biofilm formation, and quorum sensing in the multidrug-resistant, hypervirulent A. baumannii AB5075 and the susceptible, moderately virulent A. baumannii A118 strains.
Results and discussion
Transcriptome analysis of A. baumannii strain AB5075 and AB5075 Δhns revealed a differential expression profile of 183 genes with an FDR-adjusted P-value < 0.05 and log2-fold change > 1. Among the differentially expressed-genes (DEGs), we identified genes associated with motility, biofilm formation, quorum sensing, antibiotic resistance, metabolism, and stress response (Supplementary Table S1). As the aim of the present work is to identify the possible role of H-NS in antibiotic resistance only those genes, directly or indirectly associated with antibiotic resistance were examined (Supplementary Table S2).
H-NS plays a role in modulating the expression of antibiotic resistance associated genes
Analyzed RNA-seq data showed that the expression of genes related to resistance to β-lactams, aminoglycosides, quinolones, chloramphenicol, trimethoprim, sulfonamides, and colistin were up-regulated in AB5075 Δhns strain (Fig. 1A). On the other hand, genes related to tetracycline resistance were down-regulated in the Δhns strain compared to the parental strain. To confirm the RNA-seq results, transcript analysis of A. baumannii AB5075, AB5075 Δhns and AB5075 Δhns pMBLe-hns cells was performed, showing an enhanced expression on seven out of eight genes (blaOXA-23, blaOXA-51-like, blaADC, blaGES-14, carO, pbp1, and advA) associated with β-lactam resistance in AB5075 Δhns mutant strain (Fig. 1B and Supplementary Fig. S1A). In addition, the increased expression of all the selected genes associated with aminoglycoside, quinolone, chloramphenicol, trimethoprim and sulfonamide resistance in AB5075 Δhns strain was confirmed by quantitative RT-PCR (qRT-PCR) assays (Fig. 1B and Supplementary Fig. S1A). Consistently, the mutant strain containing the plasmid pMBLe-hns, which expresses a wild-type copy of hns under the control of its own promoter, rescued the expression for all resistance-related genes tested to wild type levels (Fig. 1B). These results provide evidence indicating that H-NS is involved in modulating the expression of resistance-related genes.
In order to further expand our knowledge about antibiotic resistance regulation, qRT-PCR experiments were carried out using the susceptible and less virulent A. baumannii A118 strain. This isolated was selected since it is an A. baumannii representative strains that we and other authors have been using in previous works as a model strain11–24. This strain belongs to a different lineages respect to AB5075 strain, A118 is a sporadic clone while AB5075 is a representative strain of one of the most prevalent clones (GC1). We observed that, four out of five (blaOXA-51-like, pbp1, pbp3, and carO) genes associated with β-lactam resistance as well as the fluoroquinolone resistance gene fusA were up-regulated (Supplementary Fig. S1B).
To test the effect of H-NS on the antibiotic susceptibility profile of A. baumannii strains, disk diffusion and minimal inhibitory concentration (MIC) measurements were performed (Supplementary Tables S3 and S4 and Supplementary Fig. S2). Observing disk diffusion, an increase in the halo of 4 mm or more was observed for meropenem, imipenem, amikacin and gentamicin for both strains, considering significantly according to CLSI breakpoints (Supplementary Table S3). MICs revealed twofold, threefold, threefold and fivefold decreases in AB5075 Δhns for meropenem, imipenem, amikacin and gentamicin, respectively (Supplementary Table S4 and Supplementary Fig. S2), changing from resistant to susceptible for gentamicin and amikacin, and resistant to intermediate for imipenem. In the A118 strain, a highly susceptible strain, slight changes in MICs values were observed in the Δhns strain for the carbapenems antibiotics (Supplementary Table S4). However, significant fold-decreases were observed for amikacin and gentamicin MICs (Supplementary Table S4). Changes in MIC were not observed for ceftazidime, ciprofloxacin, norfloxacin, and colistin for both strains (Table S4).
Overall, an increase in expression of the analyzed antibiotic resistance genes is observed in Δhns mutant strains suggesting a pleiotropic modulation of gene expression. The increased expression of some genes cannot be correlated with the respective phenotype, such as the increase expression of aphA6 and aadB and the increase in susceptibility for amikacin and gentamicin, respectively. However, because antibiotic resistance mechanisms are multifactorial and other uncharacterized or unknown genes might be involved, H-NS could be partially responsible for the observed phenotypes.
A previous analysis using metallo-β-lactamases (MBLs) and DNA-damaging agents as stressors9, showed that the AB5075 Δhns strain showed diminished ability to overcome stress9. Moreover, imipenem MICs of strains expressing the different MBLs, showed a detrimental impact on the antibiotic resistance phenotype in the Δhns background9. In addition, the increased susceptibility to imipenem observed in both mutant strains can be explained in part by the significant increase in expression of carO (Supplementary Table S4, and Fig. 1 and Supplementary Fig. S1), a correlation between the expression of CarO and the outer membrane permeation to imipenem in A. baumannii has been reported25,26.
The reduced MICs observed in the present work for carbapenems and aminoglycosides in the mutant background, could be related with the role of H-NS in stress response. In accordance with this result, RNA-seq analysis of the AB5075 mutant strain showed the regulation of genes that encode for proteins involved in counteracting stressful conditions, such as cspE, cspG, ywrO, hsp40, slt, mltB, katE, soxR and soxS genes (Supplementary Table S1). Diverse stress conditions, such as oxidative stress, mediated by global regulatory genes like SoxR, which is a global repressor protein involved in multidrug-resistance in Gram negative bacteria, cause the overexpression of efflux pumps contributing to multidrug-resistance phenotype 27. A recent in vitro study showed that under consecutive imipenem stress, A. baumannii evolved the ability to reduce susceptibility to various antimicrobials, including carbapenem, through overproduction of the RND super-family efflux pump 28. In other Gram-negative bacteria, as in Vibrio cholerae, it was shown that the loss of H-NS is involved in inducing an endogenous envelope/oxidative stress 29.
To further determine if changes at the transcriptional levels of efflux pumps could contribute to the altered antibiotic resistance phenotype in the Δhns mutant background, the transcriptomic data of AB5075 Δhns vs. AB5075 was examined. Our results showed that the expression of genes encoding AdeABC, AdeIJK as well as the efflux pump EmrAB were enhanced in AB5075 Δhns; however, the expression of genes that encode for AdeFGH were decreased (Fig. 2A and Supplementary Table S2). qRT-PCR experiments further confirmed up-regulation of efflux pump genes in both A. baumannii Δhns mutant strains when compared with otherwise isogenic wild-type strains (Fig. 2B and Supplementary S3). In trans complementation restored the expression levels for these genes in the AB5075 strain. The up-regulation of efflux pumps can be related with the wide regulatory effects of H-NS causing transcriptional changes in genes related with A. baumannii’s adaptative response.
We observed a wide transcriptional response in the Δhns mutant, pointing out the central role of H-NS in modulating expression/repression of a wide variety of antibiotic resistance genes. Our results confirmed a pleiotropic role of H-NS as a transcriptional regulator that is playing a critical role in reprogramming the A. baumannii transcriptome related with antibiotic resistance and stress response.
Biofilm and Quorum sensing networks are also affected by H-NS
The transcriptomic comparison of A. baumannii AB5075 Δhns against the parental strain showed that expression of csu operon, which is essential for A. baumannii biofilm formation30, was significantly down-regulated (Fig. 3A and Supplementary Table S2). The differential expression of csuA/B and csuE was further confirmed to be down-regulated by qRT-PCR analysis in AB5075 Δhns (Fig. 3B), while the AB5075 Δhns pMBLe-hns restored the wild-type level of expression of both csu genes analyzed. In addition, the changes in expression of these genes were correlated with the associated phenotype, since biofilm formation was significantly lower in AB5075 Δhns with respect to the parental strain (Fig. 3C). The rescued strain showed a slightly increment of biofilm formation compared to the Δhns strain, however, statistics differences were not observed between mutant and complementary strain (Fig. 3C). Decreased biofilm formation was also seen in A118 Δhns and a decreased in the expression level of csuE was also observed in the mutant background (Supplementary Fig. S4A,B). Levels of expression of ompA, that encodes for the OmpA protein, partially involved in abiotic biofilm formation and known to be a virulence factor31, were up-regulated in both mutants strains (Fig. 3B and Supplementary Fig. S4A).
It is known that in a biofilm the microorganisms reside and communicate with each other through quorum sensing mechanisms32. AB5075 transcriptomic data analysis revealed an upregulation of the lactonase enzyme coding aidA gene and genes encoding enzymes that participate in acyl homoserine lactone (AHL) synthesis (kar, acdA, fadD, abaI, abaR and abaM)33,34 in the mutant strain compared to wild type strain (Fig. 3A and Supplementary Table S2). The quorum network genes aidA, abaI, kar, and fadD were confirmed to be up-regulated in AB5075 Δhns mutant strains by qRT-PCR and the levels of expression were restored in hns complemented strain (Fig. 3B). Moreover, the levels of expression of aidA and abaI genes were observed to be up-regulated in the susceptible model strain A118 (Supplementary Fig. S4A). In addition, we assessed the levels of AHL using Agrobacterium tumefaciens-based solid plate assays35,36. The supernatants from cultures of AB5075 or AB5075 Δhns produced similar intensity of color, likely caused by an increase of both lactonase activity (quorum quenching) and AHL synthesis (quorum sensing) in the mutant strain (Fig. 3D). The lower AHL production observed in the AB5075 Δhns pMBLe-hns can be explained by the decrease expression of genes associated with AHL synthesis (abaI, karD, and fadD) and the higher lactonase expression levels responsible of quorum quenching activity (aidA), therefore in this strain the degradation of AHL is more evident. Finally, AHL analysis for A118 Δhns showed lower intensity of blue color compared to A118 wild type strain (Supplementary Fig. S4C). This result suggested the production of a lactonase activity that is able to counteract the levels of large chain AHLs synthesized by this strain in the assayed conditions.
The genome-wide role of H-NS in A. baumannii was first studied in a hypermotile derivative of the reference strain ATCC 179787. Transcriptomic analysis of the ATCC 17978 Δhns (strain 17978hm) identified 152 genes as DEGs (91 genes up-regulated and 61 down- regulated) when compared to the parental. The most striking up-regulation was observed in the quorum sensing genes encoding AbaI and the regulator AbaR. On the other hand, phenotypic and genetic analysis of biofilm coding genes showed no major differences between the wild type and mutant strains7. Our transcriptomic and phenotypic data compared to that of ATCC 17978, demonstrated that H-NS regulon components might vary in a strain-specific manner consistent with the fact that different A. baumannii isolates can display significant variations in phenotypes known to be controlled by H-NS (i.e., cell surface hydrophobicity, adherence and motility)37.
Conclusion
Our present work further contributes to deciphering the role of the H-NS global regulator in the control of transcription of antibiotic resistance-related mechanisms.Using distinct A. baumannii model strains, an extensive H-NS-controlled transcriptional response was observed. Our results reinforce the complexity of the regulatory network control by the transcriptional repressor H-NS that regulates the expression of genes involved in antibiotic resistance and persistence. Overall, H-NS exerts a pleiotropic role in A. baumannii, influencing the expression of a wide variety of genes related to antibiotic resistance and stress response, suggesting that it is a good candidate to develop further alternative treatment approaches to combat A. baumannii infections.
Materials and methods
Bacterial strains
The multidrug and hypervirulent AB5075 strain and its isogenic h-ns mutant (AB5075 Δhns) were used in the present study. AB5075 Δhns was obtained from the A. baumannii AB5075 transposon mutant library38. In addition, to extend the role of H-NS on the response of A. baumannii, the model susceptible A118 and its isogenic mutant A118 Δhns were used. A. baumannii A118 Δhns was obtained as previously described39. Briefly, chromosomal DNA of AB5075 Δhns (hns::TETR) was used to naturally transform the A118 strain and mutant cells were selected on Luria–Bertani (LB) agar plates supplemented with 30 µg/mL tetracycline (TET). A118 Δhns mutant strain was confirmed by automated DNA sequencing. Growth curves confirmed no differences in growth between the mutant and the complemented strains respect to the parental strains (Supplementary Fig. S5).
Electroporation
Electro-competent A. baumannii AB5075 Δhns cells were prepared and mixed with 25 ng of pMBLe-hns plasmid DNA (containing apramycin resistance) followed by electroporation with a Bio-Rad Gene Pulser instrument at 2.5 kV, 200 Ω, 25 µF. The electroporated cells were placed in recovery with 1 ml of LB broth for 2 h at 37 °C in a shaking incubator followed by culturing overnight at 37 °C on LB agar containing 15 µg/ml apramycin. At least 10 colonies were picked to confirm the presence of the different plasmids. To confirm their presence, plasmid extraction followed by gel electrophoresis analysis.
RNA extraction and RNA-seq analysis
A. baumannii AB5075 and AB5075 Δhns cells were cultured in LB broth and incubated with agitation for 18 h at 37 °C. Overnight cultures were then diluted 1:10 in fresh LB broth and incubated with agitation for 7 h at 37 °C. The Direct-zol RNA Kit (Zymo Research, Irvine, CA, USA) was used to perform the RNA extraction in triplicates. RNA samples were DNase treated (Thermo Fisher Scientific, Waltham, MA, USA) following manufacturer’s instruction. Samples were confirmed to have no DNA contamination through PCR amplification of the 16S rDNA gene. RNA sequencing was outsourced to Novogene (Novogene Corporation, Sacramento, CA, USA). Ribosomal RNA-depletion was done using the Ribo-Zero kit (Illumina) and the construction of the cDNA library was performed with the TruSeq Stranded Total RNA Library Prep kit (Illumina) from three independent replicates per sample. Analysis of the quality of the illumina reads, trimming of low-quality bases and removal of Illumina adapters was performed as described previously17. Reads were aligned to the genome of A. baumannii AB5075 using Burrows-Wheeler Alignment (BWA) software (v0.7.17) BWA and visualized using the Integrative Genomics Viewer (IGV). Read counts per gene were calculated using FeatureCounts40, and differential expression analysis was performed using DEseq2. Differentially expressed genes (DEGs) were defined as those displaying an FDR adjusted P-value of < 0.05 and log2fold change > 1. RNA-seq data generated as a result of this work has been deposited to SRA with the accession GSE167117.
qRT-PCR was performed to confirm and analyze the expression with antibiotic associated genes. cDNA was prepared using the iScript Reverse Transcription Supermix for qRT-PCR (BioRad, Hercules, CA, USA) and quantitative PCR was performed using iQ™SYBR Green Supermix (BioRad, Hercules, CA, USA) per the manufacturer’s recommendations, respectively. Results were analyzed using the 2−ΔΔCt method in which recA13 acted as the control gene. Experiments were performed in technical and biological triplicates. The results from experiments performed were statistical analyzed (t test) using GraphPad Prism (GraphPad software, San Diego, CA, USA). A P-value < 0.05 was considered significant.
Antimicrobial susceptibility assay
Antimicrobial commercial disks (BBL, Cockeysville, MD, USA) containing 10 μg of meropenem (MEM), 10 μg of ampicillin (AMP), 30 μg cefotaxime (CTX), 30 μg of ceftazidime (CAZ), 10 μg of imipenem (IMP), 15 μg of tigecycline (TIG), 30 μg of minocycline (MIN), 5 μg of ciprofloxacin (CIP), 10 μg of norfloxacin (NOR), 300 units of polymyxin B (PB), 30 μg of amikacin (AMK) and 10 μg of gentamicin (GN) were used. The inoculated plates were incubated at 37 °C for 18 h. MICs against were performed using the reference methods agar dilution according to CLSI Standards41. Antimicrobial commercial E-strips (Liofilchem S.r.l., Italy) for meropenem (MEM), ampicillin (AMP), ceftazidime (CAZ), imipenem (IMP), ciprofloxacin (CIP), norfloxacin (NOR), amikacin (AN), and gentamicin (GN) were used. Mueller–Hinton agar plates were incubated at 37 °C for 18 h. CLSI breakpoints were used for interpretation41. The MIC for colistin susceptibility testing was determined using ComASP Kit(Liofilchem) and following the manufacturer’s instructions.
Biofilm assays
Biofilms assays were performed as described in previous work13. A. baumannii cells were cultured in LB broth with agitation for 18 h at 37 °C. Overnight cultures were centrifuged at 5000 rpm at 4 °C for 5 min. Pelleted cells were washed twice with 1X phosphate buffered saline (PBS) and then re-suspended in 1X PBS. The optical density at 600 nm (OD600) of each culture was then adjusted to 0.9–1.1 and the samples were the vortexed and diluted 1:100 in LB broth in technical triplicates, the inoculated 96-well polystyrene micro-titer platewas incubated at 37 °C for 24 h without agitation. The following day, the OD600 (ODG) was measured using a micro-plate reader (SpectraMaxM3 microplate/ cuvette reader with SoftMax Pro v6 software) to determine the total biomass. Wells were emptied using a vacuum pipette, washed three times with 1X PBS and stained with 1% crystal violet (CV) for 15 min. Excess CV was removed by washing three more times with 1X PBS and the biofilm associated with the CV was solubilized in ethanol acetate (80:20) for 30 m. The OD580 (ODB) was measured using a micro-plate reader and results were reported as the ratio of biofilm to total biomass (ODB/ODG). Experiments were performed in triplicates, with at least three technical replicates per biological replicate.
N-acyl homoserine lactone (AHL) detection
Agrobacterium tumefaciens-based solid plate assays were carried out to detect N-Acyl Homoserine Lactone (AHL) production42 as described in previous work36. Initially, 500 µL of the homogenate were loaded in a central well of 0.7% LB agar plates supplemented with 40 µg of 5-bromo-3-indolyl-b-d-galactopyranoside (X-Gal) per mL and 250 µL (OD = 2.5) of the overnight culture of Agrobacterium tumefaciens biosensor. The presence of AHL was determined by the development of blue coloring35. As a positive control, 100 µL of N-Decanoyl-dl-homoserine lactone (C10-AHL) 12.5 mg/mL was utilized. Quantification of 5,5′-dibromo-4,4′-dichloro-indigo production in different conditions was determined using ImageJ software (NIH) by measuring the intensity of each complete plate, and subtracting the intensity measured in the negative control. The values were normalized to the positive control, which received the arbitrary value of 100.
Growth of A. baumannii strains
To test the ability of the A. baumannii A118 and AB5075 wild-type and derivative strains used in this work, 1/100 dilutions of overnight cultures grown in LB were inoculated in LB. Cultures were subsequently grown in agitation at 37 °C. Optical density of 600 nm was measured using a micro-plate reader (SpectraMax M3 microplate/cuvette reader with SoftMax Pro v6 software).
Statistical analysis
Experiments performed at least in triplicates were statistically analyzed by ANOVA followed by Tukey’s multiple comparison test using GraphPad Prism (GraphPad software, San Diego, CA, USA). A P-value < 0.05 was considered significant.
All procedures performed in this study were in accordance with the CSUF Institutional Biosafety Committee Approval plan (DBH117-01) and are in compliance with the NIH, CDC, OSHA and other environmental and occupational regulations.
Supplementary Information
Author contributions
D.R., C.L., C.P., M.R.T., T.S., J.E., B.N., R.A.B, M.E.T. and M.S.R. conceived the study and designed the experiments. D.R., C.L., C.P., M.R.T., T.S., J.E., B.N., R.S., and M.S.R. performed the experiments and genomics and bioinformatics analyses. D.R., C.L., C.P., M.R.T., T.S., E.G.V., R.S., R.A.B., M.E.T. and M.S.R. analyzed the data and interpreted the results. R.A.B., M.E.T. and M.S.R. contributed reagents/materials/analysis tools. M.R.T., T.S., E.G.V., R.S., R.A.B., M.E.T. and M.S.R. wrote and revised the manuscript. All authors read and approved the final manuscript.
Funding
The authors’ work was supported by NIH SC3GM125556 to MSR, R01AI100560 to RAB, R01AI063517, R01AI072219 to RAB and 2R15 AI047115 to MET. CP and JE were supported by Grant MHRT 2T37MD001368 from the National Institute on Minority Health and Health Disparities, National Institute of Health. DR has a MARC U*STAR fellowship by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number T34GM008612. This study was supported in part by funds and/or facilities provided by the Cleveland Department of Veterans Affairs, Award Number 1I01BX001974 to RAB from the Biomedical Laboratory Research & Development Service of the VA Office of Research and Development and the Geriatric Research Education and Clinical Center VISN 10 to RAB. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Department of Veterans Affairs. PICT 2017-1627 from the National Agency of Scientific and Technology Promotion to EGV. MRT and TS are recipient of a postdoctoral fellowship from CONICET. R.S. is a staff member from CONICET.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-021-98101-w.
References
- 1.Adams MD, et al. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob. Agents Chemother. 2009;53:3628–3634. doi: 10.1128/AAC.00284-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Russo TA, et al. The response regulator BfmR is a potential drug target for Acinetobacter baumannii. mSphere. 2016;1:3. doi: 10.1128/mSphere.00082-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Marchand I, Damier-Piolle L, Courvalin P, Lambert T. Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob. Agents Chemother. 2004;48:3298–3304. doi: 10.1128/AAC.48.9.3298-3304.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Lin MF, Lin YY, Yeh HW, Lan CY. Role of the BaeSR two-component system in the regulation of Acinetobacter baumannii adeAB genes and its correlation with tigecycline susceptibility. BMC Microbiol. 2014;14:119. doi: 10.1186/1471-2180-14-119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Chen CC, Chou MY, Huang CH, Majumder A, Wu HY. A cis-spreading nucleoprotein filament is responsible for the gene silencing activity found in the promoter relay mechanism. J. Biol. Chem. 2005;280:5101–5112. doi: 10.1074/jbc.M411840200. [DOI] [PubMed] [Google Scholar]
- 6.Dorman CJ. Virulence gene regulation in Shigella. EcoSal Plus. 2004;1:1. doi: 10.1128/ecosalplus.8.9.3. [DOI] [PubMed] [Google Scholar]
- 7.Eijkelkamp BA, et al. H-NS plays a role in expression of Acinetobacter baumannii virulence features. Infect. Immun. 2013;81:2574–2583. doi: 10.1128/IAI.00065-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Deveson Lucas D, et al. Emergence of high-level colistin resistance in an Acinetobacter baumannii clinical isolate mediated by inactivation of the global regulator H-NS. Antimicrob. Agents Chemother. 2018;62:7. doi: 10.1128/AAC.02442-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Huang F, et al. The H-NS regulator plays a role in the stress induced by carbapenemase expression in Acinetobacter baumannii. MSphere. 2020;5:4. doi: 10.1128/mSphere.00793-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Niu T, et al. Wza gene knockout decreases Acinetobacter baumannii virulence and affects Wzy-dependent capsular polysaccharide synthesis. Virulence. 2020;11:1–13. doi: 10.1080/21505594.2019.1700659. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Martinez J, et al. Cerebrospinal fluid (CSF) augments metabolism and virulence expression factors in Acinetobacter baumannii. Sci. Rep. 2021;11:4737. doi: 10.1038/s41598-021-81714-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Martinez J, et al. Human pleural fluid triggers global changes in the transcriptional landscape of Acinetobacter baumannii as an adaptive response to stress. Sci. Rep. 2019;9:17251. doi: 10.1038/s41598-019-53847-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Quinn B, et al. Human serum albumin alters specific genes that can play a role in survival and persistence in Acinetobacter baumannii. Sci. Rep. 2018;8:14741. doi: 10.1038/s41598-018-33072-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Domingues S, et al. Competence for natural transformation is common among clinical strains of resistant Acinetobacter spp. Microorganisms. 2019;7:30. doi: 10.3390/microorganisms7020030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Domingues S, Rosario N, Ben Cheikh H, Da Silva GJ. ISAba1 and Tn6168 acquisition by natural transformation leads to third-generation cephalosporins resistance in Acinetobacter baumannii. Infect. Genet. Evol. 2018;63:13–16. doi: 10.1016/j.meegid.2018.05.007. [DOI] [PubMed] [Google Scholar]
- 16.Vesel N, Blokesch M. Pilus production in Acinetobacter baumannii is growth phase dependent and essential for natural transformation. J. Bacteriol. 2021;203:3. doi: 10.1128/JB.00034-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Rodman Nyah MJ, et al. Human pleural fluid elicits pyruvate and phenylalanine metabolism in Acinetobacter baumannii to enhance cytotoxicity and immune evasion. Front. Microbiol. 2019;10:1581. doi: 10.3389/fmicb.2019.01581. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Martinez, J. et al. Human fluids alter DNA-acquisition in Acinetobacter baumannii. Diagn Microbiol Infect Dis (2018). [DOI] [PMC free article] [PubMed]
- 19.Quinn B, Martinez J, Liu C, Nguyen M, Ramirez MS. The effect of sub-inhibitory concentrations of antibiotics on natural transformation in Acinetobacter baumannii. Int. J. Antimicrob. Agents. 2018;51:809–810. doi: 10.1016/j.ijantimicag.2018.01.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Ramirez MS, et al. Identification of potential virulence factors in the model strain Acinetobacter baumannii A118. Front. Microbiol. 2019;10:1599. doi: 10.3389/fmicb.2019.01599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Traglia GM, Quinn B, Schramm ST, Soler-Bistue A, Ramirez MS. Serum albumin and Ca2+ are natural competence inducers in the human pathogen Acinetobacter baumannii. Antimicrob. Agents Chemother. 2016;60:4920–4929. doi: 10.1128/AAC.00529-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Ramirez MS, Adams MD, Bonomo RA, Centron D, Tolmasky ME. Genomic analysis of Acinetobacter baumannii A118 by comparison of optical maps: identification of structures related to its susceptibility phenotype. Antimicrob. Agents Chemother. 2011;55:1520–1526. doi: 10.1128/AAC.01595-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Ramirez MS, et al. Naturally competent Acinetobacter baumannii clinical isolate as a convenient model for genetic studies. J. Clin. Microbiol. 2010;48:1488–1490. doi: 10.1128/JCM.01264-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Le, C. et al. Interplay between meropenem and human serum albumin on expression of carbapenem resistance genes and natural competence in Acinetobacter baumannii. Antimicrob. Agents Chemother. AAC0101921 (2021). [DOI] [PMC free article] [PubMed]
- 25.Mussi MA, Limansky AS, Viale AM. Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: Natural insertional inactivation of a gene encoding a member of a novel family of beta-barrel outer membrane proteins. Antimicrob. Agents Chemother. 2005;49:1432–1440. doi: 10.1128/AAC.49.4.1432-1440.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Mussi MA, et al. Horizontal gene transfer and assortative recombination within the Acinetobacter baumannii clinical population provide genetic diversity at the single carO gene, encoding a major outer membrane protein channel. J. Bacteriol. 2011;193:4736–4748. doi: 10.1128/JB.01533-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Alibert S, et al. Multidrug efflux pumps and their role in antibiotic and antiseptic resistance: A pharmacodynamic perspective. Expert. Opin. Drug. Metab. Toxicol. 2017;13:301–309. doi: 10.1080/17425255.2017.1251581. [DOI] [PubMed] [Google Scholar]
- 28.Zhang Y, et al. Overproduction of efflux pumps caused reduced susceptibility to carbapenem under consecutive imipenem-selected stress in Acinetobacter baumannii. Infect. Drug. Resist. 2017;11:457–467. doi: 10.2147/IDR.S151423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Wang H, Ayala JC, Benitez JA, Silva AJ. RNA-seq analysis identifies new genes regulated by the histone-like nucleoid structuring protein (H-NS) affecting Vibrio cholerae virulence, stress response and chemotaxis. PLoS ONE. 2015;10:e0118295. doi: 10.1371/journal.pone.0118295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Tomaras AP, Flagler MJ, Dorsey CW, Gaddy JA, Actis LA. Characterization of a two-component regulatory system from Acinetobacter baumannii that controls biofilm formation and cellular morphology. Microbiology. 2008;154:3398–3409. doi: 10.1099/mic.0.2008/019471-0. [DOI] [PubMed] [Google Scholar]
- 31.Gaddy JA, Tomaras AP, Actis LA. The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect. Immun. 2009;77:3150–3160. doi: 10.1128/IAI.00096-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Carradori S, et al. Biofilm and quorum sensing inhibitors: The road so far. Expert. Opin. Ther. 2020;30:917–930. doi: 10.1080/13543776.2020.1830059. [DOI] [PubMed] [Google Scholar]
- 33.Lopez M, et al. Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzyme. PLoS ONE. 2017;12:e0174454. doi: 10.1371/journal.pone.0174454. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Lopez-Martin M, Dubern JF, Alexander MR, Williams P. AbaM regulates quorum sensing, biofilm formation and virulence in Acinetobacter baumannii. J. Bacteriol. 2021;38:444. doi: 10.1128/JB.00635-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Cha C, Gao P, Chen YC, Shaw PD, Farrand SK. Production of acyl-homoserine lactone quorum-sensing signals by gram-negative plant-associated bacteria. Mol. Plant Microbe Interact. 1998;11:1119–1129. doi: 10.1094/MPMI.1998.11.11.1119. [DOI] [PubMed] [Google Scholar]
- 36.Pimentel C, et al. Human pleural fluid and human serum albumin modulate the behavior of a hypervirulent and multidrug-resistant (MDR) Acinetobacter baumannii representative strain. Pathogens. 2021;10:471. doi: 10.3390/pathogens10040471. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.McQueary CN, Actis LA. Acinetobacter baumannii biofilms: Variations among strains and correlations with other cell properties. J. Microbiol. 2011;49:243–250. doi: 10.1007/s12275-011-0343-7. [DOI] [PubMed] [Google Scholar]
- 38.Gallagher LA, et al. Resources for genetic and genomic analysis of emerging pathogen Acinetobacter baumannii. J. Bacteriol. 2015;197:2027–2035. doi: 10.1128/JB.00131-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Wilharm G, Piesker J, Laue M, Skiebe E. DNA uptake by the nosocomial pathogen Acinetobacter baumannii occurs during movement along wet surfaces. J. Bacteriol. 2013;195:4146–4153. doi: 10.1128/JB.00754-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Quinlan AR, Hall IM. BEDTools: A flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26:841–842. doi: 10.1093/bioinformatics/btq033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.(CLSI), C.L.S.I. Performance standards for antimicrobial susceptibility testing: Twenty-nine informational supplement. CLSI Document M100-S29:2019. Clinical Lab Standards Institute (2019).
- 42.Paulk Tierney AR, Rather PN. Methods for detecting N-acyl homoserine lactone production in Acinetobacter baumannii. Methods Mol. Biol. 2019;1946:253–258. doi: 10.1007/978-1-4939-9118-1_23. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.